An Evaluation of Biopsy Results Adenocancer in Patient with Serum Prostate-Spesific Antigen Less 4 ng/ml


Creative Commons License

Yilmaz A. H., Ziypak T., ADANUR Ş., Demirdogen S. O., ÖZBEY İ., Demirel A., ...Daha Fazla

JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, cilt.6, ss.448-451, 2015 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 6
  • Basım Tarihi: 2015
  • Doi Numarası: 10.4328/jcam.3514
  • Dergi Adı: JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.448-451
  • Erzincan Binali Yıldırım Üniversitesi Adresli: Hayır

Özet

Aim: In this study we aimed to assess patients with prostate cancer which suspected prostate cancer with digital rectal examination and PSA levels less than 4 ng/ml. Material and Method: 846 patients were recruited from who diagnosed with prostate cancer in our clinic between January 2004 and May 2013. Their biopsy results, PSA levels, digital rectal examination findings, prostate volume and trans-rectal ultrasound images were evaluated retrospectively. 17 patients had PSA levels less than 4 ng/ml. One patient biopsy was transitional cell carcinoma, so that he was out of the study. Results: The mean age was 69.7 for these patients. The mean PSA levels was 2.3 ng/ml and mean prostat volume was 38 cm3. Nodules were detected in six patients, asymmetry was detected in nine patients and capsular irregularity was detected in six patients with digital rectal examination. Seven patients had hypoechoic lesion in trans-rectal ultrasound images. Discussion: As there is no definitive diagnostic PSA levels for prostate cancer, there is no cut off value of PSA. Several patients who have PSA levels less than 4 ng/ml may have clinically significant, organ confined prostat cancers in prostate biopsy.